financetom
Business
financetom
/
Business
/
Guardian Pharmacy Services Shares Advance in Nasdaq Debut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Guardian Pharmacy Services Shares Advance in Nasdaq Debut
Sep 26, 2024 9:41 AM

11:10 AM EDT, 09/26/2024 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) shares were up over 9% in recent Thursday trading as the company's stock debuted on Nasdaq and opened above its initial public offering price of $14 per share.

The company's IPO of 8 million common shares is expected to close on Friday.

Price: 15.35, Change: +1.35, Percent Change: +9.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SmartFinancial Q3 Adjusted Earnings, Revenue Rise
SmartFinancial Q3 Adjusted Earnings, Revenue Rise
Oct 21, 2025
05:36 PM EDT, 10/21/2025 (MT Newswires) -- SmartFinancial ( SMBK ) reported Q3 adjusted earnings late Tuesday of $0.86 per diluted share, up from $0.54 a year earlier. Analysts polled by FactSet expected $0.72 per share. Revenue for the three months ended Sept. 30, expressed as the sum of net interest income and noninterest income, rose to $51.1 million from...
National Bank Q3 Earnings, Revenue Rise
National Bank Q3 Earnings, Revenue Rise
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- National Bank ( NBHC ) reported adjusted Q3 earnings late Tuesday of $0.96 per diluted share, up from $0.86 a year earlier. Analysts polled by FactSet expected $0.85. Revenue, expressed as the sum of net interest income and total noninterest income, for the quarter ended Sep. 30 was $108.9 million, up from $106.0...
Bitfarms Closes Offering of Senior Notes due 2031
Bitfarms Closes Offering of Senior Notes due 2031
Oct 21, 2025
05:34 PM EDT, 10/21/2025 (MT Newswires) -- Bitfarms ( BITF ) said late Tuesday it closed a $588 million offering of 1.375% convertible senior notes due 2031. The offering includes the full exercise by underwriters to purchase up to an additional $88 million of the notes, according to a statement. Net proceeds of around $568 million will be used to...
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Alector's Latozinemab Fails in Phase 3 Dementia Trial; Workforce Cut by 49%; Shares Fall After Hours
Oct 21, 2025
05:44 PM EDT, 10/21/2025 (MT Newswires) -- Alector ( ALEC ) said Tuesday that its Phase 3 trial of latozinemab in frontotemporal dementia caused by a progranulin gene mutation failed to meet its primary clinical endpoint. The company will halt the continuation study for latozinemab and reduce its workforce by 49%. Sara Kenkare-Mitra, president and head of research and development,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved